← All organizations
Highest phase reached
Phase 4
First clinical trial
May 1, 2015Last known activity
Apr 30, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (9 distinct, 6 trials)
Phase 4 (3 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Indications
Recent trials (14)
- NCT05772975Overall official - principal investigatorPhase 3Apr 30, 2023
- NCT05772975Sponsor investigatorPhase 3Apr 30, 2023
- NCT05772975Lead sponsorPhase 3Apr 30, 2023
- NCT05048121Lead sponsorN/AJul 24, 2021
- NCT04558697Study chairPhase 4Mar 21, 2019
- NCT04558697Reponsible party - principal investigatorPhase 4Mar 21, 2019
- NCT04558697Lead sponsorPhase 4Mar 21, 2019
- NCT04198948Lead sponsorPhase 1Mar 4, 2019
- NCT04198948Overall official - principal investigatorPhase 1Mar 4, 2019
- NCT04198948Reponsible party - principal investigatorPhase 1Mar 4, 2019
- NCT04867993Lead sponsorN/AAug 28, 2018
- NCT04867993Reponsible party - principal investigatorN/AAug 28, 2018
- NCT02249429CollaboratorPhase 1/Phase 2May 1, 2015
- NCT02249429Overall official - principal investigatorPhase 1/Phase 2May 1, 2015
Details
- Last known activity
- Apr 30, 2023